South Dakota Investment Council Spectrum Pharmaceuticals Inc Transaction History

South Dakota Investment Council

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$1.83 - $3.45 $127,734 - $240,810	-69,800 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$7.03 - $9.7 $290,964 - $401,473	41,389 Added 145.68%	69,800 $579,000
Q1 2019 May 03, 2019	BUY	$9.08 - $11.84 $26,431 - $34,466	2,911 Added 11.42%	28,411 $304,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $421,260 - $632,910	25,500 New	25,500 $428,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.